Company intelligence / Profile preview

NeuroHydrate

Connecticut, United Statesneurohydrate.com ↗

Ownership: Private
Development stage: Commercial

Overview

NeuroHydrate has developed and commercialized a nutritional supplement ("HM-Formula") aimed at supporting brain health, particularly for individuals suffering from migraines and headaches. The company claims high customer satisfaction rates (>80% would recommend), but their products are not FDA-approved drugs nor intended to diagnose, treat, cure, or prevent any disease[1][2]. Clinical results in the pharmaceutical sense are not available.

Therapeutic areas: Neurology
Modalities: Small moleculeNutritional supplement
Industry: Food & Nutrition

Drug pipeline

1 asset

HM-Formula

Commercial

Indications: Migraine prevention

Partnerships

Partnerships with neurologists in New England for market research trials and HCP network engagement

Beyond the preview

Go deeper on NeuroHydrate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroHydrate.

Explore the full profile